Evidence map›Paper›PMID 41726517›Full record

ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2024

Generating Counterfactual Patient Timelines from Real-World Data.

Yu Akagi, Tomohisa Seki, Toru Takiguchi, Hiromasa Ito, Yoshimasa Kawazoe, Kazuhiko Ohe

Abstract read
In one paragraph

Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yu AkagiDepartment of Biomedical Informatics, Graduate School of Medicine, The University of Tokyo, Japan.
Tomohisa SekiDepartment of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.
Toru TakiguchiDepartment of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.
Hiromasa ItoDepartment of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.
Yoshimasa KawazoeDepartment of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.
Kazuhiko OheDepartment of Biomedical Informatics, Graduate School of Medicine, The University of Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Counterfactual simulation-exploring hypothetical consequences under alternative clinical scenarios-holds promise for transformative applications such as personalized medicine and in-silico trials. However, it remains challenging due to methodological limitations. Here, we show that an autoregressive generative model, trained on real-world data from over 300,000 patients and 400 million patient timeline entries, can generate clinically plausible counterfactual trajectories. As a validation task, we applied the model to patients hospitalized with COVID-19 in 2023, modifying age, serum C-reactive protein (CRP), and serum creatinine to simulate 7-day outcomes. Increased in-hospital mortality was observed in counterfactual simulations with older age, elevated CRP, and elevated serum creatinine. Remdesivir prescriptions increased in simulations with higher CRP values and decreased in those with impaired kidney function. These counterfactual trajectories reproduced known clinical patterns. These findings suggest that autoregressive generative models trained on real-world data in a self-supervised manner can establish a foundation for counterfactual clinical simulation.

Indexed as

COVID-19Adenosine MonophosphateAlanineAntiviral AgentsComputer SimulationCOVID-19 Drug TreatmentC-Reactive ProteinCreatinineGenerative Artificial IntelligenceHospital MortalityHumansAdenosine MonophosphateAlanineAntiviral AgentsC-Reactive ProteinCreatinineremdesivir

Identifiers

PMID41726517
PMCPMC12919531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.